SCHEMBL375093

SCHEMBL375093

COc1cccc(CNC2CCOCC2)c1

nearest known ligand 0.76

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.76
TSHR P16473 1/20 0.54
KDM1A O60341 2/20 0.53
MAOB P27338 2/20 0.53
MAOA P21397 1/20 0.53
LMNA P02545 1/20 0.51
PKM P14618 1/20 0.51
HTT P42858 1/20 0.51
PRMT5 O14744 2/20 0.50
WDR77 Q9BQA1 2/20 0.50
PDE2A O00408 1/20 0.50
HTR6 P50406 1/20 0.49
PDCD1 Q15116 1/20 0.49
CD274 Q9NZQ7 1/20 0.49
MTNR1A P48039 1/20 0.48
MTNR1B P49286 1/20 0.48
CHRM2 P08172 1/20 0.48
MAPT P10636 1/20 0.46
TACR1 P25103 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1040185 0.90 ALDH1A1 (0.88) ALDH1A1TSHRKDM1AMAOBMAOA
SCHEMBL5678905 0.85 ALDH1A1 (0.97) ALDH1A1TSHRKDM1AMAOBMAOA
SCHEMBL374658 0.84 ALDH1A1 (0.55) ALDH1A1KDM1AMAOBMAOAHTT
SCHEMBL8690941 0.83 ALDH1A1 (0.76) ALDH1A1TSHRKDM1AMAOBMAOA
SCHEMBL374999 0.82 ALDH1A1 (0.52) ALDH1A1PRMT5WDR77PDCD1CD274
SCHEMBL375222 0.82 CARM1 (0.61) ALDH1A1PRMT5WDR77
SCHEMBL25609125 0.82 MEN1 (0.57) ALDH1A1TSHRKDM1ALMNA
SCHEMBL15587413 0.81 ACHE (0.60) ALDH1A1MAOBPRMT5WDR77PDE2A
SCHEMBL17308302 0.81 ALDH1A1 (0.49) ALDH1A1PRMT5WDR77PDCD1CD274
SCHEMBL30010506 0.79 ALDH1A1 (0.52) ALDH1A1TSHRKDM1AMAOBMAOA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8623898-B2 Glycine transporter inhibiting substances TAISHO PHARMACEUTICAL CO., LTD. (JP) 2014-01-07 US disclosed
EP-2409976-A1 GLYCINE TRANSPORTER INHIBITOR Taisho Pharmaceutical Co., Ltd. (JP) 2012-01-25 EP disclosed
US-20120010414-A1 GLYCINE TRANSPORTER INHIBITING SUBSTANCES TAISHO PHARMACEUTICAL CO., LTD. (JP) 2012-01-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120010414-A1 GLYCINE TRANSPORTER INHIBITING SUBSTANCES SLC18A2, SLC1A2, SLC6A1 ALDH1A1 1730/4885TSHR 724/4885KDM1A 4445/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.